文献速递心脑血管急症

WTAP介导的KLF6 m6A修饰加重缺氧/复氧诱导的人心肌细胞损伤

WTAP-MEDIATED M6A MODIFICATION OF KLF6 AGGRAVATES HYPOXIA/REOXYGENATION-INDUCED HUMAN CARDIOMYOCYTE INJURY.
PubMed 文献 · Shock · 2024-04-09
一句话结论WTAP通过m6A修饰稳定KLF6 mRNA,加重缺氧/复氧诱导的人心肌细胞凋亡、炎症、氧化应激和铁死亡,为心肌梗死提供潜在治疗策略。

该研究探讨KLF6在缺氧/复氧(H/R)诱导的人心肌细胞(AC16)损伤中的作用及机制。结果显示,KLF6和WTAP在心肌梗死患者血清及H/R诱导的AC16细胞中mRNA和蛋白水平均显著上调;KLF6沉默可减轻H/R诱导的AC16细胞凋亡、炎症反应、氧化应激和铁死亡;WTAP通过调控KLF6的m6A修饰稳定其mRNA;WTAP敲低通过降低KLF6表达挽救H/R诱导的AC16细胞损伤。结论提示WTAP介导的KLF6 m6A修饰加重心肌细胞损伤,为心肌梗死提供治疗策略。

要点

  • KLF6和WTAP在心肌梗死患者血清及H/R诱导的AC16细胞中mRNA和蛋白水平均显著上调。
  • KLF6沉默减轻H/R诱导的AC16细胞凋亡、炎症反应、氧化应激和铁死亡。
  • WTAP通过调控m6A修饰稳定KLF6 mRNA。
  • WTAP敲低通过降低KLF6表达挽救H/R诱导的AC16细胞凋亡、炎症、氧化应激和铁死亡。
  • 作者认为WTAP介导的KLF6 m6A修饰为心肌梗死提供治疗策略。

适用人群与场景

  • 心肌梗死患者血清样本及H/R诱导的人心肌细胞(AC16)模型

研究设计与关键结果

  • 研究类型:基础实验(细胞及血清样本),未报告样本量。
  • KLF6和WTAP在心肌梗死患者血清及H/R诱导的AC16细胞中mRNA和蛋白水平较对照组显著上调。
  • KLF6沉默减轻H/R诱导的AC16细胞凋亡、炎症反应、氧化应激和铁死亡。
  • WTAP通过调控KLF6的m6A修饰稳定KLF6 mRNA。
  • WTAP敲低通过降低KLF6表达挽救H/R诱导的AC16细胞凋亡、炎症反应、氧化应激和铁死亡。

证据类型、等级与局限

  • 证据类型:基础实验研究(细胞实验及临床血清样本)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为WTAP介导的KLF6 m6A修饰加重H/R诱导的心肌细胞损伤,为心肌梗死提供治疗策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Myocardial infarction (MI) is a severe condition that typically results from the ischemia and necrosis of heart muscle. Kruppel-like factor 6 (KLF6) can aggravate myocardial ischemia/reperfusion injury. This work aims to reveal its role and mechanism in hypoxia/reoxygenation (H/R)-induced cardiomyocyte injury. Methods: Human cardiomyocyte (AC16) was exposed to hypoxic treatment to mimic MI-like cell injury. mRNA expression levels of KLF6 and WT1-associated protein (WTAP) were detected by quantitative real-time polymerase chain reaction. Protein expression was detected by western blotting assay. Cell viability was assessed by CCK-8 assay. Cell apoptosis and cell cycle were investigated by flow cytometry. Enzyme-linked immunosorbent assays were conducted to detect IL-1β, TNF-α and IL-6 levels. Fe 2+ colorimetric assay kit was used to detect Fe 2+ level. MDA Content Assay Kit was used to detect MDA level. Cellular ROS Assay kit was applied to assess ROS level. The association of KLF6 and WTAP was identified by RNA immunoprecipitation assay and dual-luciferase reporter assay. Results: KLF6 and WTAP expression at mRNA and protein levels were significantly upregulated in serum samples of MI patients and H/R-induced AC16 cells when compared with control groups. KLF6 silencing attenuated H/R-induced AC16 cell apoptosis, inflammatory response, oxidative stress, and ferroptosis. Additionally, WTAP stabilized KLF6 mRNA by regulating its m6A modification. Furthermore, WTAP knockdown rescued H/R-induced AC16 cell apoptosis, inflammatory response, oxidative stress, and ferroptosis by decreasing KLF6 expression. Conclusion: WTAP-mediated m6A modification of KLF6 aggravated hypoxia/reoxygenation-induced apoptosis, inflammatory response, oxidative stress, and ferroptosis of human cardiomyocytes, providing a therapeutic strategy for MI.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Fang M, Li T, Wu Z, et al. WTAP-MEDIATED M6A MODIFICATION OF KLF6 AGGRAVATES HYPOXIA/REOXYGENATION-INDUCED HUMAN CARDIOMYOCYTE INJURY. Shock. 2024. PMID: 38662610. doi:10.1097/SHK.0000000000002373

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。